Premier Research is expanding its presence in the Asia-Pacific region to include South Korea, Singapore, and Taiwan – with greater health care spending and patient access to new drugs driving demand.
Chiltern has acquired Integrated Development Associates Co. Ltd. (IDA), a Japenese contract research organization (CRO) with offices in Japan, Korea, and Southeast Asia.
A recent spate of activity - including the acquisition of a Japanese CRO and a secondary equity offering - has boosted Quintiles’ investment appeal, an analyst says.
In a sign of further industry consolidation, CRO Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. Financial terms of the deal were not announced.
West has begun production at its second manufacturing facility in China, driven by the growing market for pharma injectable components in the Asia pacific region.
The global pharma packaging market - worth $47.5bn (Eur35.87bn) in 2011 - is expected to grow to $73bn in 2018, with a CAGR of 5.6%, according to a report by Transparency Market Research.
Quintiles has added to its commercial services capabilities in the Middle East and North Africa (MENA) region through an agreement with UAE-based Dayarn Pharma.
Quintiles will bring its commercial activities within the Asia-Pacific region in-house after selling its share of jointly established company Invida Group.
Contract research organisation (CRO) Chiltern says new Australia and Singapore offices are a natural progression for its contract research business in the Asia-Pacific region.
US firm 3M Drug Delivery Systems has set its sights on the Asia-Pacific region, with a new lab in Singapore which, it says, will help it better serve both local and international markets.
Australia's clinical trial industry is taking steps to promote
itself further on the world stage, along with the forging of closer
ties with the budding Asia-Pacific region.
Quintiles' subsidiary Pharmalink has acquired the marketing rights
to Eli Lilly India's flagship antibiotic brand Distaclor (cefaclor)
in a bid to boost its core services business.
ATMI LifeSciences, a Belgian company that manufactures and supplies
film-based single-use packaging products for the biopharmaceutical
industry, has set up a joint venture, ATMI Austar LifeSciences,
Ltd, in the Shanghai area of China.
Both Agilent and Applied Biosystems (ABI) have announced new
facilities in Asia and are looking to gain from the increasing
pharmaceutical industry presence in the region.
As the Asia-Pacific continues to be a hotspot for clinical trials
activity, e-clinical provider ClinPhone has opened its first office
in the region in the hope of gaining a head start.
For the first time in its 30-year history, the biotechnology
industry in 2005 surpassed $60bn (€49bn) in revenues according to
Ernst & Young's 2006 Global Biotechnology Report, an astounding
growth considering that in 1996...
UK-based Lock Inspection Systems, a leading manufacturer of
weighing and metal detection system, has announced the opening of a
regional commercial office for Asia-Pacific to meet with growing
demand for its products across the region.